A Randomized, Controlled Study of Kan Jang versus Amantadine in the Treatment of Influenza in Volgograd
Author:
Publisher
Informa UK Limited
Subject
Pharmacology,Biochemistry
Link
http://www.tandfonline.com/doi/pdf/10.1080/J157v03n01_04
Reference10 articles.
1. Prevention of common colds with Andrographis paniculata dried extract. A Pilot double blind trial
2. Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study
3. A double-blind study with a new monodrug Kan Jang: Decrease of symptoms and improvement in the recovery from common colds
4. Controlled clinical study of standardized Andrographis paniculata extract in common cold — a pilot trial
5. Double-blind, placebo-controlled pilot and Phase III study of activity of standardized Andrographis paniculata Herba Nees extract fixed combination (Kan jang) in the treatment of uncomplicated upper-respiratory tract infection
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Andrographolide, diterpenoid constituent of Andrographis paniculata: Review on botany, phytochemistry, molecular docking analysis, and pharmacology;Annales Pharmaceutiques Françaises;2024-01
2. Dynamic Model of Andrographolide Therapy for COVID-19;2023 IEEE 5th Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability;2023-12-21
3. Andrographis: Immune Modulating and Anti-Inflammatory Effects;Integrative and Complementary Therapies;2023-10-01
4. Efficacy of Kan Jang® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial;Pharmaceuticals;2023-08-22
5. Comparative pharmacokinetics and safety evaluation of high dosage regimens of Andrographis paniculata aqueous extract after single and multiple oral administration in healthy participants;Frontiers in Pharmacology;2023-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3